; BioClinica, Inc. (BIOC) - Financial and Strategic SWOT Analysis Review
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

BioClinica, Inc. (BIOC) - Financial and Strategic SWOT Analysis Review

VIEWS: 5 PAGES: 40

BioClinica, Inc. (BioClinica) is a provider of clinical trial management services to companies in pharmaceutical, biotechnology, and medical device domain. The company products and services related to medical image management, Electronic Data Capture (EDC), clinical data management, interactive voice and web response, clinical trial supply forecasting, Clinical Trial Management Systems (CTMS), and electronic image transport and archiving. It has operational facilities in Pennsylvania, the US; Leiden, The Netherlands; Lyon, France; and Bhubaneshwar, India. The company is headquartered in Newtown, Pennsylvania, the US. The company focuses on nurturing partnerships as a key element of its strategy, as recently it partnered with ClinPlan to deliver clinical supply simulation services in conjunction with its BioClinica Optimizer tool; partnered with Paragon Solutions to support large-scale integration of BioClinica's eClinical solutions.

More Info
  • pg 1
									         BioClinica, Inc. (BIOC) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME9FSA                                                                                              Publication Date: AUG 2012

          826 Newtown-Yardley Road                           Phone              +1 267 7573000                  Revenue          84 (million USD)
          Newtown, PA                                        Fax                +1 267 7573010                  Net Profit       2.80 (million USD)
          18940                                              Website            www.bioclinica.com              Employees        522
          United States                                      Exchange           BIOC [NASDAQ]                   Industry         Medical Equipment

       Company Overview
       BioClinica, Inc. (BioClinica) is a provider of clinical trial management services to companies in pharmaceutical, biotechnology,
       and medical device domain. The company products and services related to medical image management, Electronic Data Capture
       (EDC), clinical data management, interactive voice and web response, clinical trial supply forecasting, Clinical Trial Management
       Systems (CTMS), and electronic image transport and archiving. It has operational facilities in Pennsylvania, the US; Leiden, The
       Netherlands; Lyon, France; and Bhubaneshwar, India. The company is headquartered in Newtown, Pennsylvania, the US.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      BioClinica, Inc., SWOT Analysis
         Mark L. Weinstein                   Chief Executive Officer                  Strengths                              Weaknesses
         David E. Nowicki                    Chairman
                                                                                      Product and Services Offerings Business Dependence
         Jeffrey H. Berg, Ph.D.              Director
                                                                                      Increment in Revenues and
         E. Martin Davidoff                  Director
                                                                                      Order Backlogs
         Adeoye Y. Olukotun, M.D             Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     New Business Contracts                 Global Economic Scenario
         BioClinica, Inc.
                                                                                      Key Business Partnerships              Rapid Technological Change
        Share Price (USD) as on 03-Aug-                                  5.21
        2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (USD)                                                        0.17        GlobalData
        Market Cap (million USD)                                           81
        Enterprise Value (million USD)                                     70
        Shares Outstanding (million)                                       16
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Aug 01, 2012         Luitpold Pharma Chooses BioClinica's Express
                                                                                                           EDC
                                                                                      Jul 18, 2012         ClinPlan Chooses BioClinica Optimizer For
                                                                                                           Clinical Supply Chain Simulation
                                                                                      May 09, 2012         BioClinica Reports Revenue Of $22.7m In Q1
                                                                                                           2012
                                                                                      Feb 28, 2012         Amarin Corporation          Chooses       BioClinica
                                                                                                           eClinical Suite
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




BioClinica, Inc. (BIOC) - Financial and Strategic SWOT Analysis                                                                     Reference Code: GDME9FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       BioClinica, Inc. - Key Facts................................................................................................................................................................. 5
       BioClinica, Inc. - Key Employees........................................................................................................................................................ 6
       BioClinica, Inc. - Key Employee Biographies...................................................................................................................................... 8
       BioClinica, Inc. - Major Products and Services ................................................................................................................................... 9
       BioClinica, Inc. - History ................................................................................................................................................................... 10
       BioClinica, Inc. - Company Statement .............................................................................................................................................. 13
       BioClinica, Inc. - Locations And Subsidiaries ................................................................................................................................... 14
          Head Office ................................................................................................................................................................................... 14
          Other Locations & Subsidiaries ..................................................................................................................................................... 14
       Section 2 – Company Analysis ......................................................................................................................................................... 15
       BioClinica, Inc. - Business Description ............................................................................................................................................. 15
       BioClinica, Inc. - Corporate Strategy ................................................................................................................................................ 17
       BioClinica, Inc. - SWOT Analysis ..................................................................................................................................................... 18
          SWOT Analysis - Overview........................................................................................................................................................... 18
          BioClinica, Inc. - Strengths............................................................................................................................................................ 18
             Strength - Product and Services Offerings ................................................................................................................................ 18
             Strength - Increment in Revenues and Order Backlogs ............................................................................................................ 18
             Strength - Operational Network ................................................................................................................................................. 18
          BioClinica, Inc. - Weaknesses ...................................................................................................................................................... 18
             Weakness - Business Dependence .......................................................................................................................................... 18
          BioClinica, Inc. - Opportunities...................................................................................................................................................... 19
             Opportunity - New Business Contracts...................................................................................................................................... 19
             Opportunity - Key Business Partnerships .................................................................................................................................. 19
             Opportunity - Market Prospects: Healthcare IT Domain ............................................................................................................ 19
          BioClinica, Inc. - Threats ............................................................................................................................................................... 20
             Threat - Global Economic Scenario........................................................................................................................................... 20
             Threat - Rapid Technological Change ....................................................................................................................................... 20
             Threat - Stringent Government Regulations .............................................................................................................................. 20
             Threat - Intense Competitive Pressures .................................................................................................................................... 20
       BioClinica, Inc. - Key Competitors .................................................................................................................................................... 22
       Section 3 – Company Financial Ratios ............................................................................................................................................. 23
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 23
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 23
       Performance Chart ........................................................................................................................................................................... 25
       Financial Performance...................................................................................................................................................................... 25
       Financial Ratios - Interim Ratios....................................................................................................................................................... 26
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 27
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 28
          BioClinica, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 ...................................................................................... 28
          BioClinica, Inc., Medical Equipment, Deals By Type, 2006 to YTD 2012 ..................................................................................... 29
       BioClinica, Inc., Recent Deals Summary .......................................................................................................................................... 30


BioClinica, Inc. (BIOC) - Financial and Strategic SWOT Analysis                                                                                                       Reference Code: GDME9FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Section 5 – Company’s Recent Developments ................................................................................................................................ 31
          BioClinica, Inc., Recent Developments ......................................................................................................................................... 31
             May 09, 2012: BioClinica Reports Revenue Of $22.7m In Q1 2012 ......................................................................................... 31
             Mar 30, 2012: BioClinica Enters Into Technology Integration Agreement With Mirada Medical ................................................ 31
             Mar 23, 2012: BioClinica Enters Into Technology Integration Agreement With NextDocs......................................................... 31
             Feb 28, 2012: Amarin Corporation Chooses BioClinica eClinical Suite .................................................................................... 32
             Feb 09, 2012: BioClinica Reports Revenue Of $22.4m In Q4 2011 .......................................................................................... 32
             Jan 17, 2012: Harrison Clinical Research Selects BioClinica OnPoint CTMS ........................................................................... 32
             Nov 09, 2011: BioClinica Reports Revenue Of $21.5m In Q3 2011 .......................................................................................... 33
             Sep 26, 2011: BioClinica Appoints Andrzej Dzik-Jurasz As Senior Medical Director For Medical Affairs ................................. 33
             Sep 08, 2011: OptiNose Selects BioClinica Trident IWR, Optimizer And Imaging Core Lab Solutions..................................... 34
             Aug 03, 2011: BioClinica Reports Total Revenues Of $20.4m In Q2 2011 ............................................................................... 34
								
To top